These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31576124)

  • 21. Biological Activity Of miRNA-27a Using Peptide-based Drug Delivery Systems.
    Schachner-Nedherer AL; Werzer O; Kornmueller K; Prassl R; Zimmer A
    Int J Nanomedicine; 2019; 14():7795-7808. PubMed ID: 31576124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Characterization of Cationic Nanostructured Lipid Carriers as Drug Delivery Systems for miRNA-27a.
    Tucak-Smajić A; Ruseska I; Letofsky-Papst I; Vranić E; Zimmer A
    Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular uptake and trafficking of peptide-based drug delivery systems for miRNA.
    Ruseska I; Zimmer A
    Eur J Pharm Biopharm; 2023 Oct; 191():189-204. PubMed ID: 37666365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression.
    Kim SY; Kim AY; Lee HW; Son YH; Lee GY; Lee JW; Lee YS; Kim JB
    Biochem Biophys Res Commun; 2010 Feb; 392(3):323-8. PubMed ID: 20060380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-23a regulates 3T3-L1 adipocyte differentiation.
    Shen L; Zhang Y; Du J; Chen L; Luo J; Li X; Li M; Tang G; Zhang S; Zhu L
    Gene; 2016 Jan; 575(2 Pt 3):761-4. PubMed ID: 26415879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Protocol To Characterize Peptide-Based Drug Delivery Systems for miRNAs.
    Schachner-Nedherer AL; Werzer O; Zimmer A
    ACS Omega; 2019 Apr; 4(4):7014-7022. PubMed ID: 31459813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arginine-based poly(ester amide) nanoparticle platform: From structure-property relationship to nucleic acid delivery.
    You X; Gu Z; Huang J; Kang Y; Chu CC; Wu J
    Acta Biomater; 2018 Jul; 74():180-191. PubMed ID: 29803783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A lipid-based cell penetrating nano-assembly for RNAi-mediated anti-angiogenic cancer therapy.
    Majumder P; Bhunia S; Chaudhuri A
    Chem Commun (Camb); 2018 Feb; 54(12):1489-1492. PubMed ID: 29359766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of microRNAs in obesity and obesity-related diseases.
    Iacomino G; Siani A
    Genes Nutr; 2017; 12():23. PubMed ID: 28974990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a peptide-modified siRNA nanocomplex for hepatic stellate cells.
    Zhao Z; Li Y; Jain A; Chen Z; Liu H; Jin W; Cheng K
    Nanomedicine; 2018 Jan; 14(1):51-61. PubMed ID: 28890106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Avidin, Neutravidin, and Streptavidin as Nanocarriers for Efficient siRNA Delivery.
    Jain A; Barve A; Zhao Z; Jin W; Cheng K
    Mol Pharm; 2017 May; 14(5):1517-1527. PubMed ID: 28026957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AntihypoxamiR functionalized gramicidin lipid nanoparticles rescue against ischemic memory improving cutaneous wound healing.
    Ghatak S; Li J; Chan YC; Gnyawali SC; Steen E; Yung BC; Khanna S; Roy S; Lee RJ; Sen CK
    Nanomedicine; 2016 Oct; 12(7):1827-1831. PubMed ID: 27033464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular trafficking and exocytosis of a multi-component siRNA nanocomplex.
    Shukla RS; Jain A; Zhao Z; Cheng K
    Nanomedicine; 2016 Jul; 12(5):1323-34. PubMed ID: 26970028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy.
    Dorrani M; Garbuzenko OB; Minko T; Michniak-Kohn B
    J Control Release; 2016 Apr; 228():150-158. PubMed ID: 26965957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects.
    Zhang X; Li Y; Chen YE; Chen J; Ma PX
    Nat Commun; 2016 Jan; 7():10376. PubMed ID: 26765931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension.
    McLendon JM; Joshi SR; Sparks J; Matar M; Fewell JG; Abe K; Oka M; McMurtry IF; Gerthoffer WT
    J Control Release; 2015 Jul; 210():67-75. PubMed ID: 25979327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protamine-oligonucleotide-nanoparticles: Recent advances in drug delivery and drug targeting.
    Scheicher B; Schachner-Nedherer AL; Zimmer A
    Eur J Pharm Sci; 2015 Jul; 75():54-9. PubMed ID: 25896372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-penetrating peptides as a promising tool for delivery of various molecules into the cells.
    Ruczynski J; Wierzbicki PM; Kogut-Wierzbicka M; Mucha P; Siedlecka-Kroplewska K; Rekowski P
    Folia Histochem Cytobiol; 2014; 52(4):257-69. PubMed ID: 25530464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.